These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28548306)

  • 1. Zanthoxylum avicennae extract enhances GSK-3β to attenuate β-catenin via phosphatase 2A to block metastatic effects of HA22T cells and hepatocellular carcinoma xenografted nude mice.
    Wu HC; Lay IS; Shibu MA; Ho TJ; Cheng SM; Lin CH; Dung TD; Jeng LB; Viswanadha VP; Huang CY
    Environ Toxicol; 2017 Sep; 32(9):2133-2143. PubMed ID: 28548306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zanthoxylum avicennae extracts inhibit cell proliferation through protein phosphatase 2A activation in HA22T human hepatocellular carcinoma cells in vitro and in vivo.
    Dung TD; Chang HC; Binh TV; Lee MR; Tsai CH; Tsai FJ; Kuo WW; Chen LM; Huang CY
    Int J Mol Med; 2012 Jun; 29(6):1045-52. PubMed ID: 22426520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zanthoxylum avicennae extracts induce cell apoptosis through protein phosphatase 2A activation in HA22T human hepatocellular carcinoma cells and block tumor growth in xenografted nude mice.
    Dung TD; Chang HC; Chen CY; Peng WH; Tsai CH; Tsai FJ; Kuo WW; Chen LM; Huang CY
    Int J Mol Med; 2011 Dec; 28(6):927-36. PubMed ID: 21874223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of plasminogen activators and the MMP-2/-9 pathway by a Zanthoxylum avicennae extract to inhibit the HA22T human hepatocellular carcinoma cell migration and invasion effects in vitro and in vivo via phosphatase 2A activation.
    Dung TD; Feng CC; Kuo WW; Pai P; Chung LC; Chang SH; Hsu HH; Tsai FJ; Lin YM; Huang CY
    Biosci Biotechnol Biochem; 2013; 77(9):1814-21. PubMed ID: 24018669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
    Lu WJ; Chua MS; Wei W; So SK
    Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen and ERα enhanced β-catenin degradation and suppressed its downstream target genes to block the metastatic function of HA22T hepatocellular carcinoma cells via modulating GSK-3β and β-TrCP expression.
    Chen YF; Velmurugan BK; Wang HL; Tu CC; Che RJ; Chen MC; Jen LB; Vishwanadha VP; Hsu HH; Huang CY
    Environ Toxicol; 2017 Feb; 32(2):519-529. PubMed ID: 26990689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling.
    Zhao G; Song Y; Dong L; Shi H; Li H; Yang L; Wang J
    Biochem Biophys Res Commun; 2019 Oct; 517(4):722-728. PubMed ID: 31395338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhubarb inhibits hepatocellular carcinoma cell metastasis via GSK-3-β activation to enhance protein degradation and attenuate nuclear translocation of β-catenin.
    Tsai KH; Hsien HH; Chen LM; Ting WJ; Yang YS; Kuo CH; Tsai CH; Tsai FJ; Tsai HJ; Huang CY
    Food Chem; 2013 May; 138(1):278-85. PubMed ID: 23265488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical exercise suppresses hepatocellular carcinoma progression by alleviating hypoxia and attenuating cancer stemness through the Akt/GSK-3β/β-catenin pathway.
    Xiao CL; Zhong ZP; Lü C; Guo BJ; Chen JJ; Zhao T; Yin ZF; Li B
    J Integr Med; 2023 Mar; 21(2):184-193. PubMed ID: 36781361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3β-dependent Wnt/β-catenin signaling.
    Fan W; Du F; Liu X
    Eur J Pharmacol; 2019 May; 850():109-117. PubMed ID: 30710548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apicidin-resistant HA22T hepatocellular carcinoma cells strongly activated the Wnt/β-catenin signaling pathway and MMP-2 expression via the IGF-IR/PI3K/Akt signaling pathway enhancing cell metastatic effect.
    Hsieh CH; Cheng LH; Hsu HH; Ho TJ; Tu CC; Lin YM; Chen MC; Tsai FJ; Hsieh YL; Huang CY
    Biosci Biotechnol Biochem; 2013; 77(12):2397-404. PubMed ID: 24317053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of canonical Wnt/β-catenin signaling activity by HCV core protein promotes cell growth of hepatocellular carcinoma cells.
    Liu J; Ding X; Tang J; Cao Y; Hu P; Zhou F; Shan X; Cai X; Chen Q; Ling N; Zhang B; Bi Y; Chen K; Ren H; Huang A; He TC; Tang N
    PLoS One; 2011; 6(11):e27496. PubMed ID: 22110662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lectin BS-I inhibits cell migration and invasion via AKT/GSK-3β/β-catenin pathway in hepatocellular carcinoma.
    Jian Q; Yang Z; Shu J; Liu X; Zhang J; Li Z
    J Cell Mol Med; 2018 Jan; 22(1):315-329. PubMed ID: 28922551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation therapy of hepatocellular carcinoma by inhibiting the activity of AKT/GSK-3β/β-catenin axis and TGF-β induced EMT with sophocarpine.
    Zhang PP; Wang PQ; Qiao CP; Zhang Q; Zhang JP; Chen F; Zhang X; Xie WF; Yuan ZL; Li ZS; Chen YX
    Cancer Lett; 2016 Jun; 376(1):95-103. PubMed ID: 26945965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of β-catenin/TCF/LEF signalling.
    Gao H; Yin FF; Guan DX; Feng YX; Zheng QW; Wang X; Zhu M; Zhang XL; Cheng SQ; Chen TW; Jiang H; Zhang EB; Wang JJ; Ni QZ; Yuan YM; Zhang FK; Ma N; Cao HJ; Wang YK; Li JJ; Xie D
    Cell Prolif; 2019 May; 52(3):e12583. PubMed ID: 30793395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spindle and kinetochore-associated protein 2 facilitates the proliferation and invasion of hepatocellular carcinoma via the regulation of Wnt/β-catenin signaling.
    Jiang J; Xu B; Zheng Y; Guo X; Chen F
    Exp Cell Res; 2020 Oct; 395(1):112181. PubMed ID: 32682011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astragaloside IV inhibits metastasis in hepatoma cells through the suppression of epithelial-mesenchymal transition via the Akt/GSK-3β/β-catenin pathway.
    Qin CD; Ma DN; Ren ZG; Zhu XD; Wang CH; Wang YC; Ye BG; Cao MQ; Gao DM; Tang ZY
    Oncol Rep; 2017 Mar; 37(3):1725-1735. PubMed ID: 28112375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2.
    Lim K; Han C; Dai Y; Shen M; Wu T
    Mol Cancer Ther; 2009 Nov; 8(11):3046-55. PubMed ID: 19887546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3β/β-catenin pathway.
    Ng L; Chow AKM; Man JHW; Yau TCC; Wan TMH; Iyer DN; Kwan VHT; Poon RTP; Pang RWC; Law WL
    BMC Cancer; 2018 Jun; 18(1):621. PubMed ID: 29859044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged inhibition of class I PI3K promotes liver cancer stem cell expansion by augmenting SGK3/GSK-3β/β-catenin signalling.
    Liu F; Wu X; Jiang X; Qian Y; Gao J
    J Exp Clin Cancer Res; 2018 Jun; 37(1):122. PubMed ID: 29940988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.